Literature DB >> 12244126

Role of beta(3)-endonexin in the regulation of NF-kappaB-dependent expression of urokinase-type plasminogen activator receptor.

Felicitas Besta1, Steffen Massberg, Korbinian Brand, Elke Müller, Sharon Page, Sabine Grüner, Michael Lorenz, Karin Sadoul, Waldemar Kolanus, Ernst Lengyel, Meinrad Gawaz.   

Abstract

Endothelial migration on extracellular matrix is regulated by integrins and proteolysis. Previous studies showed that beta(3)-integrins regulate expression of the urokinase-type plasminogen activator receptor (uPAR) through outside-in signalling involving the cytoplasmic domain. Here we show that overexpression of the integrin-binding protein beta(3)-endonexin decreased uPAR promoter (-398 base-pair fragment) activity that is constitutively active in endothelial cells. Mutation of the NF-kappaB promoter binding site (-45 bp) impaired the ability of beta(3)-endonexin to downregulate uPAR promoter activity. Immunoprecipitation studies showed that beta(3)-endonexin interacts directly with the p50/p65 transactivation complex and thereby inhibits binding of kappaB oligonucleotides to the p50/p65 complex. Moreover, binding of beta(3)-endonexin to p50 was inhibited in the presence of kappaB but not mutated kappaB oligonucleotides, suggesting a sterical competition between beta(3)-endonexin and kappaB DNA for the p50/p65 complex. We therefore propose that beta(3)-endonexin acts as regulator of uPAR expression in beta(3)-integrin-mediated endothelial cell migration through direct interaction with p50/p65. Since NF-kappaB regulates the expression of matrix degrading enzymes, the present results define a role of beta(3)-endonexin in regulating beta(3)-integrin-mediated adhesion and pericellular proteolysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244126     DOI: 10.1242/jcs.00081

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  6 in total

1.  Selection of early-occurring mutations dictates hormone-independent progression in mouse mammary tumor lines.

Authors:  Albana Gattelli; María N Zimberlin; Roberto P Meiss; Lucio H Castilla; Edith C Kordon
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

Review 2.  Specification of DNA binding activity of NF-kappaB proteins.

Authors:  Fengyi Wan; Michael J Lenardo
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10       Impact factor: 10.005

3.  The β3-integrin binding protein β3-endonexin is a novel negative regulator of hypoxia-inducible factor-1.

Authors:  Damir Kračun; Florian Riess; Ivan Kanchev; Meinrad Gawaz; Agnes Görlach
Journal:  Antioxid Redox Signal       Date:  2014-03-13       Impact factor: 8.401

4.  Identification of a genetic locus for autosomal dominant disseminated superficial actinic porokeratosis on chromosome 1p31.3-p31.1.

Authors:  Ping Liu; Shouyan Zhang; Qi Yao; Xiangyang Liu; Xu Wang; Changzheng Huang; Xinyuan Huang; Pengyun Wang; Mingxiong Yuan; Jing Yu Liu; Qing K Wang; Mugen Liu
Journal:  Hum Genet       Date:  2008-04-29       Impact factor: 4.132

5.  Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression.

Authors:  Lisheng Wang; Pablo Menendez; Farbod Shojaei; Li Li; Frederick Mazurier; John E Dick; Chantal Cerdan; Krysta Levac; Mickie Bhatia
Journal:  J Exp Med       Date:  2005-05-09       Impact factor: 14.307

6.  Peptides derived from the integrin β cytoplasmic tails inhibit angiogenesis.

Authors:  Zhongyuan Cao; Xinfeng Suo; Yudan Chu; Zhou Xu; Yun Bao; Chunxiao Miao; Wenfeng Deng; Kaijun Mao; Juan Gao; Zhen Xu; Yan-Qing Ma
Journal:  Cell Commun Signal       Date:  2018-07-03       Impact factor: 5.712

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.